Authors
Latest:
Equitable Representation in Triple-Negative Breast Cancer Clinical TrialsBlack women have higher rates of triple-negative breast cancer (TNBC) incidence and mortality than the general US population. Despite this, they are underrepresented in TNBC clinical trials.
Latest:
The Patient Journey: Navigating TD From Young Adults to Older OnesPanelists discuss how the patient journey with tardive dyskinesia involves evolving awareness and management of symptoms alongside underlying psychiatric conditions, highlighting the distinct needs of younger vs older patients and the essential role of pharmacists in supporting individualized, function-focused care throughout the lifespan.
Latest:
Point-of-Care Testing Offers New Opportunities for Pharmacy TechniciansBecoming experts in medical billing for point-of-care testing offers a new avenue for technicians to excel and show their value.
Latest:
Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial IntelligenceArtificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
Latest:
Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple MyelomaIntegration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
Latest:
Proper Use of Automation in Hazardous Drug Compounding PharmaciesAlthough robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.
Latest:
NCCN Flash Update: Linvoseltamab Added as Preferred Regimen After 4 Prior Therapies for Multiple MyelomaThe National Comprehensive Cancer Network (NCCN) has released multiple myeloma guidelines version 2.2026 to include linvoseltamab as a preferred treatment for heavily pretreated patients, highlighting its intravenous formulation, dosing options, and streamlined Risk Evaluation and Mitigation Strategy program.
Latest:
Specialty Drug Commercialization Process and ConsiderationsAs specialty drugs move through clinical trials and preparations for commercialization begin, significant attention is warranted to this process considering the massive investments that would have been already made in the product up to this point.
Latest:
Use of Lutetium Lu-177 Vipivotide Tetraxetan to Treat Metastatic Castration-Resistant Prostate CancerThe FDA-approved, targeted radiopharmaceutical agent can contribute to a patient’s cumulative radiation exposure.
Latest:
Only a Phone Call Away: The Development of a Transplant Telepharmacy Consult Service For a Large Medical SystemTransplant patients must adhere to lifelong regimens and those caring for them must consider their regimen as the patients intersect with different parts of the health care system.
Latest:
Making “Rheum” for Biosimilars: Overcoming ReluctanceDespite the proven efficacy of biosimilars, both patients and health care providers often have some reluctance when switching from an originator drug to a biosimilar.
Latest:
Can Flexibility Fix Pharmacies? The Case for Contingent WorkersIt’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.
Latest:
Patient Navigation in the Specialty Pharmacy SpaceLack of access to novel therapies, especially within the cancer space, initiated the road to patient navigation.
Latest:
What’s Ahead in the Adalimumab Biosimilar Pipeline in DermatologyFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
You Previously Qualified for a Small Dispenser DSCSA Exemption. Now What?As welcome as this compliance extension may be for those who qualify, it is critical they understand both their current and future regulatory obligations.
Latest:
Semaglutide Carries Potential Risk of Worsening Diabetic RetinopathyDespite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Latest:
Updates in Cancer Prevention and Screening for 2025: A Pharmacist PrimerPharmacists play a vital role in cancer prevention and early detection by educating patients on risk factors, counseling on screening guidelines, and promoting adherence to evidence-based recommendations for common cancers, such as breast, cervical, colorectal, lung, prostate, and skin cancer.
Latest:
Bexagliflozin (Brenzavvy): Advancing Diabetes Management With SGLT-2 InhibitionBeyond its primary role in diabetes treatment, SGLT-2 inhibitors have demonstrated versatility in various health aspects, offering benefits beyond glucose reduction.
Latest:
The Term 'Bispecific Antibody' Is No Longer EnoughBispecific therapies require clearer terminology to improve safety and communication.
Latest:
Pharmacists Play Key Role in Managing Toxicity During Neoadjuvant Therapy for MelanomaChristine Barrett, PharmD, BCOP, shares insights, challenges, and advice for oncology pharmacists navigating neoadjuvant therapy.
Latest:
Patient-Controlled Analgesia: Pharmacy Haven or Nursing Nightmare?Patient-controlled analgesia typically consists of opioids or local anesthetics, but it may also include non-opioid analgesics or other medications.
Latest:
Little Pills, Big Risks: The Untold Dangers of Referring to Low-Dose Aspirin as 'Baby Aspirin’Aspirin, known as acetylsalicylic acid, has been marketed in ways that have de-emphasized potential risks to children.
Latest:
Comprehensive Management of Multiple Sclerosis: The Vital Role of PharmacistsMultiple sclerosis is a debilitating disease affecting many Americans. Pharmacists can help patients control the symptoms that impact their quality of life.
Latest:
Sleep and Treatments in InsomniaPharmacists should be vigilant in recognizing medications that are causing insomnia in a patient's profile or electronic medical record.
Latest:
Developing a Health-System Controlled Substance Monitoring ProgramIt is vital to have a robust controlled substance monitoring program to promptly identify and mitigate drug diversion.
Latest:
Updates on 2022 Changes to the American Diabetes Association Standards of CareMetformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.
Latest:
50 Years of Progress: Unlocking Stem Cell Transplantation for All PatientsThis year the world’s first stem cell register celebrates its 50th anniversary.
Latest:
Rare Disease Day 2022: The Pharmacist’s RolePharmacists hold a vastly underrecognized role within the care team—a role that offers a unique approach toward the therapeutic management of rare diseases.
Latest:
Time to Address the Management of Antiphospholipid SyndromeIt is vital for health care teams to recognize the signs and symptoms of antiphospholipid syndrome and to identify the severity of a patient’s diagnosis based on their aPL profile.
